Abstract:The ability of tumour cells to propagate inside the body, generating metastasis, is the cause of 90 % of cancer-associated deaths. During metastasis, cancer cells modify their migratory strategy by interacting with the surrounding environment and modulating their mechanical properties. Therefore, studying the contribution of cell biomechanics to cancer invasion could help gain a broader knowledge of the metastatic process. This work aims to develop and validate methods, techniques and platforms to study cell mechanical properties and their roles in cancer invasion. Considering that cancer cells are a heterogeneous population, we divided MDA MB 231 breast cancer cells and MDA MB 435 melanoma cancer cells into subpopulations based on their ability to move through narrow membrane pores (3um), aiming to identify the correlation between cell mechanical properties and cancer cell invasiveness. At first, we established a method to study cell elasticity and adhesion forces using atomic force microscopy. Using this technique, we found lower values of Young’s modulus and adhesion forces in the more invasive subpopulation. Transcriptome analysis, performed by our collaborators at the Beatson Cancer Institute, revealed an overexpression of the MAPK/ERK signalling pathway in these cells, causing a lower organisation of the actin filaments in the cytoskeleton and a reduction of cell stiffness and adhesion forces. We demonstrated that inhibition of the MAPK/ERK pathway, using MEK inhibitors (Trametinib and U0126), causes an increase in stiffness and adhesion forces in these cells. We also developed a high-throughput microfluidic device to investigate the link between these findings and the dynamics of cancer cell invasion in confined environments under the effect of a chemotactic gradient. Considering the influence of the tumour microenvironment in regulating the cell migratory strategy by modulating cell mechanics, we used organotypic tissue slices to develop a new platform to study cancer cell metastasis in an in vivo like model. As the first step, we developed a reliable protocol for the culture of precision cut liver slices (PCLS) to maintain their viability and morphological parameters in vitro for up to 3 days. We then established a new method to study cancer cell invasion in organotypic tissue slices. Using the MDA MB 231 cells as the model system to validate the platform, we observed that more invasive subpopulation of cells showed higher invasiveness than the original population in liver tissue, which is in agreement with previous results using the other methods or platforms (i.e. Boyden chambers, wound healing assay, collagen matrix, and in vivo model). Similar results were found in the following experiment investigating MDA MB 231 migration in organotypic brain slices. To explore the potential of this in vivo like platform for preclinical oncological drug testing, throughput had to be considered. To this end, we combined this platform with a microfluidic device previously developed for high-throughput drug testing on tissue slices and further improved the culturing technique, which resulted in increased viability and higher maintenance of morphological features for up to 7 days. The combination of this new platform with the microfluidic device could, in future, allow the simultaneous study of the effects of several drugs on cell metastasis in an in vivo like environment replicating the metastatic site.

Ex vivo model of breast cancer cell invasion in live lymph node tissue

Modeling Tumor: Lymphatic Interactions in Lymphatic Metastasis of Triple Negative Breast Cancer

State of the Art Modelling of the Breast Cancer Metastatic Microenvironment: Where Are We?

Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes

Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2 breast cancer

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8 + T Cells During Tumorigenesis

Modeling Structural Elements and Functional Responses to Lymphatic-Delivered Cues in a Murine Lymph Node on a Chip

A Novel Ex Vivo Tumor Spheroid-Tissue Model for Investigating Microvascular Remodeling and Lymphatic Blood Vessel Plasticity

Abstract 4124: Patient-derived ex vivo models to test drug responses of disseminated cancer cells in various metastatic niches

An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche

Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast Cancer

Effector Lymphocyte-Induced Lymph Node-Like Vasculature Enables Naive T-cell Entry into Tumours and Enhanced Anti-Tumour Immunity.

Single Cell Profiling of Primary and Paired Metastatic Lymph Node Tumors in Breast Cancer Patients

The contribution of cell mechanical properties to cancer metastasis

Spatiotemporal quantification of metastatic tumour cell growth and distribution in lymph nodes by whole-mount tissue 3D imaging

Reprogramming of sentinel lymph node microenvironment during tumor metastasis

Abstract PR002: Lymph node colonization reprograms lymphocyte responses to generate systemic tolerance and promote distant metastasis

Microenvironment components and spatially resolved single-cell transcriptome atlas of breast cancer metastatic axillary lymph nodes

Organotypic Platform for Studying Cancer Cell Metastasis.

Abstract A171: A fully human tissue-based ex vivo cell migration analysis model to study T-cell infiltration and distribution in colorectal cancer liver metastases

Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model